Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (ESPR) is a publicly traded company in the Unknown sector. Across all available filings, 47 corporate insiders have executed 339 transactions totaling $333.6M, demonstrating a bearish sentiment with -$64.7M in net insider flow. The most recent transaction on Dec 17, 2025 involved a sale of 6,517 shares valued at $23.9K.
ESPR Insider Activity Summary
Who Is Buying ESPR Stock?
No significant insider buying has been recorded for ESPR in the recent period.
Who Is Selling ESPR Stock?
No significant insider selling has been recorded for ESPR in the recent period.
Is Esperion Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ESPR is bearish with an Insider Alignment Score of 40/100 and a net flow of -$64.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ESPR Frequently Asked Questions
Understanding ESPR Insider Activity
Insider trading at Esperion Therapeutics, Inc. (ESPR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 47 insiders are actively trading ESPR stock, having executed 339 transactions in the past 90 days. The most active insider is Patrick G. Enright (Executive), who has made 28 transactions totaling $75.2M.
Related Tools
Track Esperion Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ESPR file new Form 4 transactions